GRYPHON ADVISORS, LLC

Thesis

Gryphon Investors, founded in 1995 and headquartered in San Francisco, is a private equity firm managing over $10.0 billion in AUM. They focus on the U.S. middle market, specializing in leveraged acquisitions, recapitalizations, and restructurings. Their investment strategy is sector-focused, with a strong emphasis on healthcare (provider services, hospital/major facilities, non-reimbursement) and also includes business services, consumer products/services, industrial growth, cybersecurity, information technology, edtech, financial services, and software. Gryphon prefers control or shared-control positions in North American companies. For private equity deals, they typically invest $50 million to $500 million in companies with EBITDA up to $80 million, engaging in traditional buyouts, buy-and-build, and growth buyouts. For junior capital investments, the range is $5 million to $25 million, often in non-lead positions. Their strategy prioritizes value creation through strategic and operational enhancements, supported by a team of over 60 investment professionals, 15+ operating partners, and 65+ executive advisors. They actively pursue synergistic add-on acquisitions. As of March 31, 2026, their reported AUM was over $9.3 billion, with over $8.3 billion in private fund GAV.

Related lists

• Series C+ Fintech investors
• Series C+ Security investors
• Series C+ investors based in San Francisco, CA